Medical Director and Principal Investigator Velocity Clinical Research Los Angeles, California, United States
Join a discussion with one of your peers on the efficacy, safety, dosing, and administration of once-weekly Mounjaro, and learn about how to get your adult patients with type 2 diabetes started on this treatment. Attendees will have the opportunity to pose questions to the faculty speaker about the data presented. Refreshments will be provided.
Please see the Important Safety Information, including Boxed Warning about possible thyroid tumors, including thyroid cancer, the Full Prescribing Information, and Medication Guide provided at the Product Theater.
This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
.jpg)
